CTKB · Cytek Biosciences, Inc.
$4.45
-0.11 (-2.41%)
At close · Jul 24
Market Cap
$575.98M
Shares
129.14M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-15 | 2026-07-09 | |
| 8-K | 2026-06-25 | 2026-06-18 | |
| 8-K | 2026-06-16 | 2026-06-10 | |
| 8-K | 2026-06-02 | 2026-05-27 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-10 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-13 | 2026-01-12 | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-24 | 2025-06-18 | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | 2025-06-18 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-15 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-05 | — | |
| 8-K | 2024-09-12 | 2024-09-09 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-11 | 2024-06-05 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-25 | 2024-06-05 | |
| 8-K | 2024-03-19 | 2024-03-17 | |
| 10-K | 2024-03-13 | 2023-12-31 | |
| 8-K | 2024-03-01 | 2024-02-28 | |
| 8-K | 2024-02-27 | 2024-02-20 | |
| 8-K | 2024-01-09 | 2024-01-08 | |
| 8-K | 2023-11-28 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-11-09 | 2023-11-07 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-06-20 | 2023-06-14 | |
| 8-K/A | 2023-05-15 | 2023-02-28 | |
| 8-K | 2023-05-09 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 2023-06-14 | |
| 10-K | 2023-03-01 | 2022-12-31 | |
| 8-K | 2023-02-28 | — | |
| 8-K | 2023-02-28 | — | |
| 8-K | 2023-02-13 | — |
Showing 1–50 of 70 filings
Key facts
CIK
1831915
CUSIP
23285D109
13F (30d)
20 filings
20 filers
Visit website
Investor relations